UPDATE 1-Tocagen's brain cancer treatment fails late-stage study, shares slump
September 12, 2019 at 06:44 AM EDT
Tocagen Inc said on Thursday its experimental treatment did not prove effective in extending life of brain cancer patients in a late-stage study, sending shares down 68%.
